J Breast Cancer.  2011 Mar;14(1):76-77. 10.4048/jbc.2011.14.1.76.

Invited Commentary: Role of Estrogen Receptor-alpha in Regulating Claudin-6 Expression in Breast Cancer Cells

• Youn HJ
• Jung SH

• KMID: 2175648
• DOI: http://doi.org/10.4048/jbc.2011.14.1.76

Abstract

No abstract available.

MeSH Terms

Breast
Breast Neoplasms
Claudins
Estrogens
Claudins
Estrogens

Reference

1. Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta. 2008. 1778:588–600.

2. Staehelin LA. Structure and function of intercellular junctions. Int Rev Cytol. 1974. 39:191–283.

3. Steed E, Balda MS, Matter K. Dynamics and functions of tight junctions. Trends Cell Biol. 2010. 20:142–149.

4. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998. 141:1539–1550.

5. Mitic LL, Anderson JM. Molecular architecture of tight junctions. Annu Rev Physiol. 1998. 60:121–142.

6. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 2005. 65:9603–9606.

7. Oliveira SS, Morgado-Díaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci. 2007. 64:17–28.

8. Offner S, Hekele A, Teichmann U, Weinberger S, Gross S, Kufer P, et al. Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy. Cancer Immunol Immunother. 2005. 54:431–445.

9. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer. 2006. 6:186.

10. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 2003. 22:2021–2033.

11. Tokés AM, Kulka J, Paku S, Szik A, Páska C, Novák PK, et al. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res. 2005. 7:R296–R305.

12. Szasz AM, Tokes AM, Micsinai M, Krenacs T, Jakab C, Lukacs L, et al. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis. Clin Exp Metastasis. 2011. 28:55–63.

13. Troy TC, Turksen K. Epidermal lineage. Methods Mol Biol. 2002. 185:229–253.

14. Quan C, Lu SJ. Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays. Carcinogenesis. 2003. 24:1593–1599.

15. Osanai M, Murata M, Chiba H, Kojima T, Sawada N. Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci. 2007. 98:1557–1562.

16. Yafang L, Qiong W, Yue R, Xiaoming X, Lina Y, Mingzi Z, et al. Role of estrogen receptor-α in regulating claudin-6 expression in breast cancer cells. J Breast Cancer. 2011. 14:20–27.

17. Kim TH, Huh JH, Lee S, Kang H, Kim GI, An HJ. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology. 2008. 53:48–55.

18. Lanigan F, McKiernan E, Brennan DJ, Hegarty S, Millikan RC, McBryan J, et al. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer. 2009. 124:2088–2097.